The medicine also delays stomach emptying, which leads to longer-lasting feelings of fullness after eating and lessens the urge to eat more food [9]
The standard research protocols for epitalon involve cyclic administration, typically 10 days on followed by extended breaks, which may allow the immune system to recalibrate during off periods
NEJM 2025 (REDEFINE-2) Novo Nordisk FDA NDA submission announcement (December 18, 2025) Eli Lilly TRIUMPH-4 topline results (December 2025) Frequently Asked Questions Retatrutide produces higher weight loss at 28.7% versus CagriSema's 20.4%a difference of 21 pounds for a 250-pound person
Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL
Early indications are that the launch should be more stable than the shortages that defined the early GLP-1 surge, with supply chains better prepared and, presumably, some degree of slack in production capacity